Dyax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.01.16	Shire plc -- Moody's assigns Baa3 issuer rating to Shire plc; stable outlook (Moodys)
22.01.16	Shire Plc Completes Acquisition Of Dyax - Quick Facts (RTTNews)
03.12.15	Dyax Gets U.S. Regulatory Approval For Acquisition By Shire (RTTNews)
03.11.15	ACAD Gets FDA Date, Insight On BIND, Mega Deals Of Monday, PRTA On Track (RTTNews)
02.11.15	MÄRKTE USA/Einkaufsmanagerindizes stützen Aktienkurse (Dow Jones)
02.11.15	Pharmakonzern Shire will US-Biotechfirma Dyax kaufen (dpa-afx)
02.11.15	Shire To Acquire Dyax In $5.9 Bln Cash Deal (RTTNews)
07.07.15	Dyax Gets FDA Breakthrough Therapy Status For DX-2930 In Hereditary Angioedema (RTTNews)
08.04.15	DYAX Prices Offering At $27/Share (RTTNews)
01.04.15	MÄRKTE USA/Schwache Daten sorgen an Wall Street erneut für Verluste (Dow Jones)
01.04.15	MÄRKTE USA/Das zweite Quartal startet bei Aktien mit Abgaben (Dow Jones)
01.04.15	MÄRKTE USA/Das zweite Quartal dürfte mit Abgaben bei Aktien starten (Dow Jones)
01.04.15	Dyax Announces Positive Results From Early Stage Trial Of DX-2930 (RTTNews)
13.12.14	Lilly's Oncology Drug Cyramza Scores FDA Approval For Another Indication (RTTNews)
03.11.14	Dyax Announces Expansion Of Phase 1b Clinical Trial Evaluating DX-2930 (RTTNews)
03.04.14	Dyax Gets FDA Approval To Expand Use Of Kalbitor To Patients 12 Years And Older (RTTNews)
28.02.14	Dyax Corp. Q4 Loss Narrows - Quick Facts (RTTNews)
26.02.14	ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High (RTTNews)
06.12.13	BSDM Gets Business, BOTA's IGLOO Building Up, PBYI Leaps To New High (RTTNews)
05.12.13	Dyax Gets Orphan Drug Status For DX-2930 In Hereditary Angioedema - Quick Facts (RTTNews)
14.10.13	Trial Updates and Public Offering - Research Report on Gilead, Celgene, Ariad, Puma Biotechnology, and Dyax (PR Newswire)
09.10.13	Dyax Prices Offering Of About 9.23 Mln Shares At $6.50/Shr - Quick Facts (RTTNews)
01.12.09	Dyax Announces FDA Approval of KALBITOR® (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older (Businesswire)
07.11.09	DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations (Businesswire)
10.02.09	Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications (Businesswire)
29.04.05	DX-88 Trials in Hereditary Angioedema To Be Featured at 4th European C (Businesswire)
15.02.05	Dyax to Present at BIO CEO & Investor Conference (Businesswire)
20.01.05	Dyax Corp. Reports Senior Management Changes (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

ABB	50.98	2.82 %	K V
Logitech Intl	80.52	0.90 %	K V
CieFinRichemont	165.00	0.82 %	K V
Kuehne+Nagel Int	214.90	0.66 %	K V
Zurich Insur Gr	609.80	0.46 %	K V
Sika	230.40	-0.22 %	K V
Nestle	89.76	-0.82 %	K V
Roche Hldg G	306.00	-1.03 %	K V
Swisscom	522.00	-1.42 %	K V
UBS Group	29.06	-1.62 %	K V

Nachrichten zu Dyax Corp.

Aktien Top/Flop

Meistgelesene Nachrichten